By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Telik, Inc. 

3165 Porter Drive

Palo Alto  California  94304  U.S.A.
Phone: 650-845-7700 Fax: 650-845-7800



Drug Discovery

Company News
MabVax Therapeutics, Inc. Receives Stockholder Approval For Name Change And Reverse Stock Split Resulting From Merger With Telik, Inc. (TELK) 9/9/2014 9:05:58 AM
Telik, Inc. (TELK) Reports Progress Toward Multiple Early Stage Milestones In The Development Of A Novel Antibody-Based Therapeutic Agent For Gastrointestinal Cancers 8/28/2014 11:18:55 AM
Telik, Inc. (TELK) Receives $1.5 Million National Cancer Institute Contract To Develop Novel Antibody-Based PET Imaging Agent For Pancreatic Cancer 8/25/2014 8:59:52 AM
San Diego's Telik, Inc. (TELK) Appoints New Board Members To Oversee Reinvigorated Cancer Pipeline 8/12/2014 5:57:39 AM
Telik, Inc. (TELK) Announces New Board Of Director Members To Oversee Reinvigorated Cancer Therapy Pipeline Resulting From The Recent Merger With MabVax Therapeutics, Inc. 8/11/2014 8:56:23 AM
Telik, Inc. (TELK) Announces Plans For Special Meeting Of Stockholders And Transition To MabVax Therapeutics, Inc. 8/4/2014 7:34:50 AM
Mintz Levin Represents San Diego-Based MabVax Therapeutics, Inc. In IPO Through Merger With Telik, Inc. (TELK) 7/11/2014 9:27:42 AM
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014 9:53:19 AM
Telik, Inc. (TELK) Announces First Quarter 2014 Financial Results 5/16/2014 6:21:53 AM
Telik, Inc. (TELK) And MabVax Therapeutics, Inc. Announce Definitive Merger Agreement 5/13/2014 9:16:53 AM